Watanabe M - Search Results

1

N-acetyltransferase 1 genetic polymorphism influences the risk of prostate cancer development.

Fukutome K, Watanabe M, Shiraishi T, Murata M, Uemura H, Kubota Y, Kawamura J, Ito H, Yatani R. Fukutome K, et al. Among authors: watanabe m. Cancer Lett. 1999 Feb 8;136(1):83-7. doi: 10.1016/s0304-3835(98)00311-5. Cancer Lett. 1999. PMID: 10211944

2

Significance of vitamin D receptor gene polymorphism for prostate cancer risk in Japanese.

Watanabe M, Fukutome K, Murata M, Uemura H, Kubota Y, Kawamura J, Yatani R. Watanabe M, et al. Anticancer Res. 1999 Sep-Oct;19(5C):4511-4. Anticancer Res. 1999. PMID: 10650802

3

Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population.

Murata M, Watanabe M, Yamanaka M, Kubota Y, Ito H, Nagao M, Katoh T, Kamataki T, Kawamura J, Yatani R, Shiraishi T. Murata M, et al. Among authors: watanabe m. Cancer Lett. 2001 Apr 26;165(2):171-7. doi: 10.1016/s0304-3835(01)00398-6. Cancer Lett. 2001. PMID: 11275366

4

Impact of genetic polymorphisms of 17-hydroxylase cytochrome P-450 (CYP17) and steroid 5alpha-reductase type II (SRD5A2) genes on prostate-cancer risk among the Japanese population.

Yamada Y, Watanabe M, Murata M, Yamanaka M, Kubota Y, Ito H, Katoh T, Kawamura J, Yatani R, Shiraishi T. Yamada Y, et al. Among authors: watanabe m. Int J Cancer. 2001 Jun 1;92(5):683-6. doi: 10.1002/1097-0215(20010601)92:5<683::aid-ijc1255>3.0.co;2-4. Int J Cancer. 2001. PMID: 11340572

5

Cytochrome P4501A1 and glutathione S-transferase M1 genotypes as risk factors for prostate cancer in Japan.

Murata M, Shiraishi T, Fukutome K, Watanabe M, Nagao M, Kubota Y, Ito H, Kawamura J, Yatani R. Murata M, et al. Among authors: watanabe m. Jpn J Clin Oncol. 1998 Nov;28(11):657-60. doi: 10.1093/jjco/28.11.657. Jpn J Clin Oncol. 1998. PMID: 9861231

6

Progression-linked overexpression of c-Met in prostatic intraepithelial neoplasia and latent as well as clinical prostate cancers.

Watanabe M, Fukutome K, Kato H, Murata M, Kawamura J, Shiraishi T, Yatani R. Watanabe M, et al. Cancer Lett. 1999 Jul 1;141(1-2):173-8. doi: 10.1016/s0304-3835(99)00102-0. Cancer Lett. 1999. PMID: 10454259

7

Mutations of ras genes are relatively frequent in Japanese prostate cancers: pointing to genetic differences between populations.

Shiraishi T, Muneyuki T, Fukutome K, Ito H, Kotake T, Watanabe M, Yatani R. Shiraishi T, et al. Among authors: watanabe m. Anticancer Res. 1998 Jul-Aug;18(4B):2789-92. Anticancer Res. 1998. PMID: 9713462

8

International comparison on ras gene mutations in latent prostate carcinoma.

Watanabe M, Shiraishi T, Yatani R, Nomura AM, Stemmermann GN. Watanabe M, et al. Int J Cancer. 1994 Jul 15;58(2):174-8. doi: 10.1002/ijc.2910580205. Int J Cancer. 1994. PMID: 8026877

9

Microsatellite instability in human prostate cancer.

Watanabe M, Imai H, Shiraishi T, Shimazaki J, Kotake T, Yatani R. Watanabe M, et al. Br J Cancer. 1995 Sep;72(3):562-4. doi: 10.1038/bjc.1995.374. Br J Cancer. 1995. PMID: 7669562 Free PMC article.

10

A clinicopathological study of p53, p21 (WAF1/CIP1) and cyclin D1 expression in human prostate cancers.

Shiraishi T, Watanabe M, Muneyuki T, Nakayama T, Morita J, Ito H, Kotake T, Yatani R. Shiraishi T, et al. Among authors: watanabe m. Urol Int. 1998;61(2):90-4. doi: 10.1159/000030295. Urol Int. 1998. PMID: 9873247

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,239 results

Search Page

Filters